What is Myhep All (Epclusa)
Liver disease caused by the Hepatitis C virus can cause both acute and chronic infections, ranging in severity from mild, lasting only a few weeks, to serious life-long illness.
MyHep All, manufactured by Mylan, has been developed to treat a chronic infection of the Hepatitis C virus. In one pack of 28 tablets, each containing 400 mg of Sofosbuvir and 100 mg of Velpatasvir. It is thanks to the combination of these two drugs that the reproduction of the virus is blocked, which contributes to the destruction of the further spread of Hepatitis C virus in the body.
MyHep All is recommended for patients of all genotypes of the virus (1-6). Moreover, the use of this drug is suitable for people with cirrhosis of the liver and those who are faced with a relapse of the disease.
Numerous studies have shown that the effect of a Myhep All combination of drugs such as Sofosbuvir and Velpatasvir is many times more effective than all previous treatment options. In addition to excellent pharmaceutical qualities, the advantage of the drug is its democratic price. From now on, every patient has the opportunity to recover from a chronic virus in just 12 weeks of taking the drug.
Where to Buy Generic Epclusa online